FewerJobs.
All jobs

Senior Product Manager, Biology

Revolution Medicines - Redwood City, California, United States

Posted May 19, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Jun 7, 2026
Salary
$186K-$233K From the posting source checked Jun 20, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$102,662 U.S. median for this role
Projected growth (BLS Employment Projections)
+5.4% - Faster than average

104% above the BLS role benchmark for product management aggregate.

Matched to SOC 11-1021 - Product Management aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function
Product From the posting source checked Jun 20, 2026
Seniority
Senior From the posting source checked Jun 20, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Jun 20, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Senior Product Manager, Biology Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a Senior Product Manager, Biology to shape products and capabilities that help Biology and Discovery teams design, execute, analyze, and learn from experiments faster, with trusted data and AI-enabled support. This role will define and deliver product strategy for Biology workflows, data products, and AI-enabled decision support on RevCore, our enterprise Data, Digital, and AI platform. The mandate is to improve experiment traceability, reduce manual data preparation, accelerate cross-study analysis, and make Biology insights easier to generate and act on. You will partner with scientists across Protein Science, Structural Biology, Screening Sciences, Sample Management, In Vivo Research, Pathology, Translational Research, Computational Biology, Data Science, ML Engineering, Data Engineering, IT, and platform teams to turn complex research workflows into intuitive, scalable products. Product surfaces may include experiment planning workflows, assay and screening result review, sample and reagent lineage, cross-study analysis, and

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.

Apply at revmed.com

Apply link not verified; last-live date unavailable.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs